NEW YORK (GenomeWeb News) – Fluidigm this week filed with the US Securities and Exchange Commission for an initial public offering of common stock.
 
The South San Francisco, Calif.-based firm did not disclose how many shares it intends to offer, and the preliminary prospectus did not provide an estimated range for the offering’s share price. However, it noted that the proposed maximum amount it intends to raise is $86.25 million.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.